Insulin-secreting pancreatic tumors and insulin-like growth hormone-secreting non-islet cell tumors can cause hypoglycemia. However, insulin-releasing paraganglioma or pheochromocytoma has almost never been reported. A 67-year-old female patient was admitted to our hospital because of headache, palpitation, perspiration, faintness, frequent sense of hunger and absent-mindedness. These intermittent symptoms had begun approximately a year before admission. On physical examination, she had high blood pressure of 150/90 mm Hg. Hormonal studies demonstrated increased urinary norepinephrine levels, and hyperinsulinemic hypoglycemia was confirmed while the patient was symptomatic. Abdominal MRI revealed a retroperitoneal mass measuring 4.5 cm in the pancreatic region. She was treated with an alpha-blocking agent to control blood pressure preceding the removal of the mass. Histopathological diagnosis was paraganglioma, and immunohistochemically insulin staining in the neoplastic cells was demonstrated. Her blood pressure normalized and hypoglycemia relieved after the operation. The patient did not have recurrence of hypoglycemia after a year of follow-up. Paraganglioma is a rare tumor of the neural crest, and co-secretion of insulin and catecholamines has been reported only by a single case report in the literature. The present patient is another case with this co-secretion.

Keywords:
Paraganglioma, Hyperinsulinemia, Hypoglycemia, Ectopic insulin secretion
1.
Service FJ: Hypoglycemic disorders. N Engl J Med 1995;332:1144–1152.
2.
Koch CA, Rother KI, Roth J: Tumor hypoglycemia linked to IGF-II; in Rosenfeld R, Roberts C Jr (eds): Contemporary Endocrinology: The IGF System. Totowa, Humana Press, 1999, pp 675–698.
3.
Daughaday WH, Trivedi B: Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 1992;75:110–115.
4.
Seckl MJ, Mulholland PJ, Bishop AE, Teale JD, Hales CN, Glaser M, Watkins S, Seckl JR: Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med 1999;341:733–736.
5.
Shames JM, Dhurandhar NR, Blackard WG: Insulin-secreting bronchial carcinoid tumor with widespread metastases. Am J Med 1968;44:632–637.
6.
Fujino K, Yamamoto S, Matsumoto M, Sunada M, Ota T: Paraganglioma associated with hypoglycemia. Intern Med 1992;31:1239–1241.
7.
Jacobs P, Wood L: Recurrent benign erythropoietin-secreting pheochromocytomas. Am J Med 1994;97:307–308.
8.
Landsberg L, Young JB: Catecholamines and the adrenal medulla; in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology, ed 8. Philadelphia, Saunders, 1992, p 669.
9.
Heath H 3rd, Edis AJ: Pheochromocytoma associated with hypercalcemia and ectopic secretion of calcitonin. Ann Intern Med 1979;91:208–210.
10.
Manger WM, Gifford RW Jr: Pheochromocytoma: current diagnosis and management. Cleve Clin J Med 1993;60:365–378.
11.
O’Brien T, Young WF Jr, Davila DG, Scheithauer BW, Kovacs K, Horvath E, Vale W, van Heerden JA: Cushing’s syndrome associated with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a phaeochromocytoma. Clin Endocrinol (Oxf) 1992;37:460–467.
12.
Sparagana M, Feldman JM, Molnar Z: An unusual pheochromocytoma associated with an androgen secreting adrenocortical adenoma: evaluation of its polypeptide hormone, catecholamine, and enzyme characteristics. Cancer 1987;60:223–231.
13.
Sano T, Saito H, Yamasaki R, Hosoi E, Kameyama K, Saito S, Hirose T, Hizawa K: Production and secretion of immunoreactive growth hormone-releasing factor by pheochromocytomas. Cancer 1986;57:1788–1793.
14.
Viale G, Dell’Orto P, Moro E, Cozzaglio L, Coggi G: Vasoactive intestinal polypeptide-, somatostatin-, and calcitonin-producing adrenal pheochromocytoma associated with the watery diarrhea (WDHH) syndrome: first case report with immunohistochemical findings. Cancer 1985;55:1099–1106.
15.
Mune T, Katakami H, Kato Y, Yasuda K, Matsukura S, Miura K: Production and secretion of parathyroid hormone-related protein in pheochromocytoma: participation of an alpha-adrenergic mechanism. J Clin Endocrinol Metab 1993;76:757–762.
16.
Hassoun J, Monges G, Giraud P, Henry JF, Charpin C, Payan H, Toga M: Immunohistochemical study of pheochromocytomas: an investigation of methionine-enkephalin, vasoactive intestinal peptide, somatostatin, corticotropin, beta-endorphin, and calcitonin in 16 tumors. Am J Pathol 1984;114:56–63.
17.
Sasaki A, Yumita S, Kimura S, Miura Y, Yoshinaga K: Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extraadrenal pheochromocytoma. J Clin Endocrinol Metab 1990;70:996–999.
18.
Hashimoto K, Suemaru S, Hattori T, Sugawara M, Ota Z, Takata S, Hamaya K, Doi K, Chretien M: Multiple endocrine neoplasia with Cushing’s syndrome due to paraganglioma producing corticotropin-releasing factor and adrenocorticotropin. Acta Endocrinol (Copenh) 1986;113:189–195.
19.
Apple D, Kreines K: Cushing’s syndrome due to ectopic ACTH production by a nasal paraganglioma. Am J Med Sci 1982;283:32–35.
20.
Lieberum B, Jaspers C, Munzenmaier R: ACTH-producing paraganglioma of the paranasal sinuses. HNO 2003;51:328–331.
21.
Kitahara M, Mori T, Seki H, Washizawa K, Amano Y, Nakahata T, Takeuchi S, Inaba H, Hotchi M, Komiyama A: Malignant paraganglioma presenting as Cushing syndrome with virilism in childhood. Production of cortisol, androgens, and adrenocorticotrophic hormone by the tumor. Cancer 1993;72:3340–3345.
22.
Park HK, Park CM, Ko KH, Rim MS, Kim YI, Hwang JH, Im SC, Kim YC, Park KO: A case of Cushing’s syndrome in ACTH-secreting mediastinal paraganglioma. Korean J Intern Med 2000;15:142–146.
23.
Omura M, Sato T, Cho R, Iizuka T, Fujiwara T, Okamoto K, Tashiro Y, Chiba S, Nishikawa T: A patient with malignant paraganglioma that simultaneously produces adrenocorticotropic hormone and interleukin-6. Cancer 1994;74:1634–1639.
24.
Linnoila RI, Lack EE, Steinberg SM, Keiser HR: Decreased expression of neuropeptides in malignant paragangliomas: an immunohistochemical study. Hum Pathol 1988;19:41–50.
25.
Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr: Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001;86:5210–5216.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.